Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+56.3%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+56.3%/yr
vs +200.3%/yr prior
Acceleration
-144.0pp
Decelerating
Percentile
P100
Near historical high
vs 3Y Ago
3.8x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$226.80M+56.7%
2024$144.70M+75.6%
2023$82.40M+38.7%
2022$59.40M+403.4%
2021$11.80M+103.9%
2020$-300.60M-3264.2%
2019$9.50M+1201.4%
2018$730000.00-
2017$0.00-
2016$0.00-